Abstract
Background
The aim of the present study was to define the proportion of different levels of family history in a cohort of consecutive breast cancer patients from the Stockholm region, and to assess whether familial breast cancer has phenotypic traits different from those of sporadic patients.
Methods
All incident breast cancer patients in a 19-month period were eligible for the study and 70% (489/696) participated. The family history and clinical parameters were obtained from questionnaires and medical records.
Results
In total 35% had a family history. Age at onset was 58.9 years in the familial group vs. 60.7 years in the sporadic patients (P = 0.14) and 8% of the familial patients had bilateral breast cancer compared to 4% in the sporadic group (P = 0.08). There were 31% node positive tumors in the sporadic group vs. 22% in the cases with family history (P = 0.04). Hormonal background, treatment and prognosis (median follow-up 4.7 years) were not related to family history.
Conclusion
In addition to high-risk familial breast and breast-ovarian cancer, constituting about 10% of all breast cancer cases, another 25% of the breast cancer cases have a family history, a group hypothetically valuable for association studies on low-risk genes. In contrast to previous reports, we did not observe a relationship between family history and phenotypic traits. A possible explanation for this can be different study design. The considerable heterogeneity in familial breast cancer means that different criteria for familiality can influence the result. Furthermore, our study was prospective and population based and included paternal inheritance.
Similar content being viewed by others
Abbreviations
- ER:
-
estrogen receptor
- HR:
-
hazard rate ratio
- RR:
-
relative risk
- CI:
-
confidence interval
- FH+:
-
patients with family history
- NS:
-
no statistically significant difference
- PgR:
-
progesterone receptor
- BRCA:
-
breast cancer gene
- HRT:
-
hormone replacement therapy
- FH:
-
family history
- FH−:
-
sporadic patients
References
Socialstyrelsen (2002) Epidemiologiskt centrum., Medicinalstyrelsen. and Socialstyrelsen. Cancerregistret. Cancer incidence in Sweden. Socialstyrelsen, Statistik. Hälsa och sjukdomar, Stockholm
Newman B, Austin MA, Lee M, King MC (1988) Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85:3044–3048
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265:2088–2090
Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676–689
Malkin D (1994) p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1198:197–213
Eng C (1998) Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol 12:701–710
Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, Ahlquist DA, Podratz KC, Pittelkow M, Hartmann LC (1998) Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128:896–899
Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289–1294
Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800–809
Weber BL, Nathanson KL (2000) Low penetrance genes associated with increased risk for breast cancer. Eur J Cancer 36:1193–1199
Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843–854
Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21:1–18
Adami HO, Hansen J, Jung B, Rimsten A (1980) Familiality in breast cancer: a case-control study in a Sweden population. Br J Cancer 42:71–77
Lynch HT, Lynch JF (1986) Breast cancer genetics in an oncology clinic: 328 consecutive patients. Cancer Genet Cytogenet 22:369–371
Lindblom A, Rotstein S, Larsson C, Nordenskjold M, Iselius L (1993) Hereditary breast cancer in Sweden: a predominance of maternally inherited cases. Breast Cancer Res Treat 24:159–165
Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J (1994) The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 179:29–32
Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H (2000) Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36:1143–1148
Doepel M, Kellokumpu IH, v Smitten KA (1995) Hereditary breast cancer in Finnish women. Eur J Surg 161:805–809
Pharoah PD, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BA (2000) Familial predisposition to breast cancer in a British population: implications for prevention. Eur J Cancer 36:773–779
Tsuchiya A, Kanno M, Nomizu T, Hatakeyama Y, Kimijima I, Abe R (1998) Clinical characteristics of breast cancer patients with family history. Fukushima J Med Sci 44:35–41
Wobbes T, van de Wiel MP, van der Sluis RF, Theeuwes AG (1987) The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol l13:119–121
Russo A, Herd-Smith A, Gestri D, Bianchi S, Vezzosi V, Rosselli Del Turco M, Cardona G (2002) Does family history influence survival in breast cancer cases? Int J Cancer 99:427–430
Molino A, Giovannini M, Pedersini R, Frisinghelli M, Micciolo R, Mandara M, Pavarana M, Cetto GL (2004) Correlations between family history and cancer characteristics in 2256 breast cancer patients. Br J Cancer 91:96–98
Anderson DE (1971) Some characteristics of familial breast cancer. Cancer 28:1500–1504
Adami HO, Hansen J, Jung B, Rimsten A (1981) Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease. Cancer 48:1688–1695
Loman N, Johannsson O, Bendahl PO, Borg A, Ferno M, Olsson H (1998) Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83:310–319
Pathology of familial breast cancer (1997) differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 349:1505–1510
Chappuis PO, Rosenblatt J, Foulkes WD (1999) The influence of familial and hereditary factors on the prognosis of breast cancer. Ann Oncol 10:1163–1170
Thalib L, Wedren S, Granath F, Adami HO, Rydh B, Magnusson C, Hall P (2004) Breast cancer prognosis in relation to family history of breast and ovarian cancer. Br J Cancer 90:1378–1381
Kinoshita T, Fukutomi T, Iwamoto E, Akashi-Tanaka S (2004) Prognosis of breast cancer patients with familial history classified according to their menopausal status. Br J Cancer 10:218–222
Magnusson C, Colditz G, Rosner B, Bergstrom R, Persson I (1998) Association of family history and other risk factors with breast cancer risk (Sweden). Cancer Causes Control 9:259–267
Olsson H, Bladstrom A (2002) A cohort study of reproductive factors and family history of breast cancer in southern Sweden. Breast Cancer Res Treat 76:203–209
Jernstrom HC, Johannsson OT, Loman N, Borg A, Olsson H (1999) Reproductive factors in hereditary breast cancer. Breast Cancer Res Treat 58:295–301
Colditz GA, Rosner BA, Speizer FE (1996) Risk factors for breast cancer according to family history of breast cancer. For the Nurses’ Health Study Research Group. J Natl Cancer Inst 88:365–371
Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410
Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013–1020
Arver B, Borg A, Lindblom A (2001) First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet Test 5:1–8
Arver B, Claro A, Langerod A, Borresen-Dale AL, Lindblom A (1999) BRCA1 screening in patients with a family history of breast or ovarian cancer. Genet Test 3:223–226
Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Hakansson S, Andersen TI, Borg A, Borresen Dale AL, Lindblom A (1997) A screening for BRCA1 mutations in breast and breast–ovarian cancer families from the Stockholm region. Cancer Res 57:2474–2477
Chen J, Hedman MZ, Arver BW, Sigurdsson S, Eyfjord JE, Lindblom A (1998) BRCA2 germline mutations in Swedish breast cancer families. Eur J Hum Genet 6:134–139
Mattsson B, Rutqvist LE, Wallgren A (1985) Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 14:64–69
Margolin S, Werelius B, Fornander T, Lindblom A (2004) BRCA1 mutations in a population-based study of breast cancer in Stockholm County. Genet Test 8:127–132
Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–949
Hutson SP (2003) Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk. Oncol Nurs Forum 30:241–246
Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324
Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643–651
Theis B, Boyd N, Lockwood G, Tritchler D (1994) Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 3:321–327
Mohammed SN, Smith P, Hodgson SV, Fentiman IS, Miles DW, Barnes DM, Millis RR, Rubens RD (1998) Family history and survival in premenopausal breast cancer. Br J Cancer 77:2252–2256
Vårdprogram Ba, Onkologiskt Centrum Stockholm-Gotland
Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, Borg A, Trent J (2003) Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci USA 100:2532–2537
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85
Peto J, Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26:411–414
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Margolin, S., Johansson, H., Rutqvist, L.E. et al. Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County. Familial Cancer 5, 309–321 (2006). https://doi.org/10.1007/s10689-006-7851-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-006-7851-3